Physician profile
Stephen Sinclair-Hall
NPI 1194386219
$10,161.89
in general payments reported to CMS, 2019-2025
29 companies · $343 in 2025
The $343 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,487 · 2020: $1,526 · 2021: $1,700 · 2022: $2,723 · 2023: $923 · 2024: $461 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066 · Travel and Lodging: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,065.93 |
| Travel and Lodging | $660.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $3,917.17 | 2019-2021 | |
| Stryker Corporation | $2,694.19 | 2021-2025 | Augment Injectable, Infinity Adaptis, Infinity |
| Treace Medical Concepts, INC. | $795.64 | 2022-2025 | |
| Smith+Nephew, INC. | $487.71 | 2019-2025 | Grafix Pl, Stravix Pl |
| Medical Device Business Services, INC. | $405.00 | 2019-2020 | |
| Kerecis Limited | $325.28 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $252.69 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $191.58 | 2022 | |
| Bioventus LLC | $165.35 | 2019-2022 | |
| Wright Medical Technology, INC. | $112.80 | 2019 | |
| Ossio INC | $112.20 | 2022 | |
| Kci USA, INC. | $108.23 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $103.51 | 2021-2022 | |
| Medtronic Vascular, INC. | $94.87 | 2019 | |
| Paratek Pharmaceuticals, INC. | $67.57 | 2025 | Nuzyra |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $38.41 | 2022-2023 | Senza |
| Zimmer Biomet Holdings, INC. | $36.44 | 2020 | |
| Accufix Surgical INC. | $36.23 | 2023 | Accu-Joint |
| Depuy Synthes Sales INC. | $32.82 | 2022 | |
| Amgen INC. | $31.89 | 2025 | Krystexxa |
| Organogenesis INC. | $31.47 | 2022 | |
| Medtronic, INC. | $21.29 | 2025 | Inceptiv |
| Grt US Holding, INC. | $17.80 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.73 | 2025 | |
| Reprise Biomedical, INC. | $14.89 | 2025 | Miro3d |
| Baxter Healthcare | $14.26 | 2025 | Perclot |
| Heron Therapeutics, INC. | $12.28 | 2022 | |
| Globus Medical, INC. | $11.86 | 2021 | |
| Orthofix Medical, INC. | $10.73 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sinclair-Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.